AzTrials
AzTrials

Condition

Heart Diseases Clinical Trials

Studies of heart diseases, matched by condition name and medical subject headings. Start with those open to enrolment.

34,019 registered studies

In numbers

Open to volunteers
6,012
Active
7,263
With results posted
3,508
All registered
34,019

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 6,012
  • Heart Failure

    Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

    • Enrolling by invitation
    • Age: 18 to 100 years
    • Observational study

    Background: More than 6.5 million people in the United States live with heart failure (HF), and more than a million new cases are diagnosed each year.

    Trial name
    NCT06280820
    Where
    2 sites in United States
    Volunteers
    2,000 people
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Can I take part? NCT06280820
  • Fibromyalgia (FM) OR Fibromyalgia Syndrome, Manuel Therapy

    Effects of Adding Vagal Neuromodulation to Manual Therapy in Women With Fibromyalgia

    • Not yet recruiting
    • Age: 18 to 65 years
    • Medical device
    • Lifestyle or therapy programme

    The aim of this study is to investigate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) added to manual therapy on pain, autonomic nervous system function, and illness perception in female patients…

    Conditions
    Fibromyalgia (FM) OR Fibromyalgia Syndrome, Manuel Therapy, Chronic Widespread Pain, Autonomic Nervous System Dysfunction
    Trial name
    NCT07894588
    Testing
    Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Manual Therapy Program, Diaphragmatic Breathing and Stretching Exercises
    Where
    Turkey (Türkiye)
    Volunteers
    44 people
    Sponsor
    Hasan Kalyoncu University
    Can I take part? NCT07894588
  • Heterozygous Familial Hypercholesterolemia (HeFH)

    EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)

    • Not yet recruiting
    • Age: 18 to 65 years
    • Phase 1/2

    A phase 1/2, two-part trial consisting of an open label dose-escalation part and a randomized, double blind, placebo-controlled part to investigate safety, tolerability, pharmacokinetics, and efficacy with EDIT-401 gene editing…

    Trial name
    NCT07894887
    Testing
    Drug: EDIT-401
    Where
    2 sites in Australia
    Volunteers
    56 people
    Sponsor
    Editas Medicine, Inc.
    Can I take part? NCT07894887
  • Cystic Fibrosis, Immunologic Deficiency Syndrome

    Natural History of Noncirrhotic Portal Hypertension

    • Recruiting
    • Age: 12 to 100 years
    • Observational study

    Background: Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood vessels of the liver. It seems to start slowly and not have many warning signs.

    Conditions
    Cystic Fibrosis, Immunologic Deficiency Syndrome, Turner Syndrome, Congenital Hepatic Fibrosis
    Trial name
    NCT02417740
    Where
    United States
    Volunteers
    400 people
    Sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Can I take part? NCT02417740
  • Cardiovascular Diseases, Arrhythmias, Cardiac

    Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study

    • Enrolling by invitation
    • Age: 18 years and older
    • Observational study
    • Medical device

    The ICE-ACCESS study is a prospective observational study designed to evaluate how procurement reliability, distribution restrictions, supply-chain interruptions, and device availability affect access to intracardiac…

    Conditions
    Cardiovascular Diseases, Arrhythmias, Cardiac, Atrial Fibrillation
    Trial name
    ICE-ACCESS (NCT07788040)
    Testing
    Intracardiac Echocardiography Catheter
    Where
    United States
    Volunteers
    200 people
    Sponsor
    Truway Health, Inc.
    Can I take part? ICE-ACCESS
  • Catecholaminergic Polymorphic Ventricular Tachycardia

    A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    • Recruiting
    • Age: 7 years and older
    • Phase 1

    This is a Phase 1b, Multicenter, Open-Label, Dose Finding Study to Investigate the Safety and Tolerability of a Single Intravenous Dose of SGT-501 in participants with catecholaminergic polymorphic ventricular tachycardia (CPVT).

    Trial name
    ARTEMIS (NCT07148089)
    Testing
    SGT-501
    Where
    5 sites in United States, Canada
    Volunteers
    18 people
    Sponsor
    Solid Biosciences Inc.
    Can I take part? ARTEMIS
  • Persistent Atrial Fibrillation

    Posterior Mitral Isthmus Line With Vein of Marshall Ethanolisation Compared With Anterior Mitral Lines in Patients With Persistent Atrial Fibrillation

    • Recruiting
    • Age: 18 to 80 years
    • Injection or infusion
    • Surgery or procedure

    The goal of this clinical study is to find out which treatment works best for people with persistent atrial fibrillation (a type of irregular heartbeat).

    Trial name
    MIVANT (NCT06962176)
    Testing
    Anterior Mitral Line Ablation, Posterior Mitral Isthmus Ablation with Vein of Marshall Ethanol Infusion
    Where
    Belgium
    Volunteers
    146 people
    Sponsor
    AZ Sint-Jan AV
    Can I take part? MIVANT
  • Atrial Fibrillation (AF), Pulmonary Embolism (PE)

    Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study

    • Not yet recruiting
    • Age: 18 years and older
    • Medical device

    This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can effectively detect blood clots in the left atrial appendage (LAA) in…

    Conditions
    Atrial Fibrillation (AF), Pulmonary Embolism (PE), Left Atrial Appendage Thrombosis
    Trial name
    ELATE-AF (NCT07647939)
    Testing
    Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus, Delayed Gated CT Scan for Left Atrial Appendage Thrombus
    Where
    United States
    Volunteers
    60 people
    Sponsor
    Northwell Health
    Can I take part? ELATE-AF
  • Metabolic Disease, Obesity

    Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

    • Recruiting
    • Age: 1 year to 100 years
    • Observational study
    • Medical device

    Background: Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels.

    Conditions
    Metabolic Disease, Obesity, Li-Fraumeni Syndrome, Cardiomyopathy
    Trial name
    NCT01143454
    Testing
    NSR IDE-MRI: Research pulse sequences
    Where
    3 sites in United States
    Volunteers
    5,000 people, healthy volunteers welcome
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Can I take part? NCT01143454
  • Arrhythmogenic Cardiomyopathy

    Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

    • Recruiting
    • Age: 18 years and older
    • Phase 2

    The goal of this clinical trial is to learn if Atorvastatin 80 mg is effective to avoid functional right ventricular deterioration in patients affected by Arrhythmogenic Cardiomyopathy.

    Trial name
    SEARCH (NCT06922994)
    Testing
    Atorvastatin 80 mg/day
    Where
    5 sites in Italy
    Volunteers
    102 people
    Sponsor
    Centro Cardiologico Monzino
    Can I take part? SEARCH

Completed, with results posted

All 2,942
  • Cardiac Transplant Disorder

    Don't Throw Your Heart Away: Patient Study 4

    • Completed
    • Age: 18 years and older
    • Results posted

    This empirical study tests whether transplant center performance data that reflect center donor acceptance rates influence patients and their family members to evaluate centers with high organ decline rates less favorably than…

    Trial name
    NCT04809051
    Testing
    Stratified Transplant Survival Metric, SRTR Information Format
    Where
    United States
    Volunteers
    71 people, healthy volunteers welcome
    Sponsor
    Carnegie Mellon University
    Can I take part? NCT04809051
  • Type 1 Diabetes, Coronary Artery Calcification

    Cardiovascular Risk Stratification in Young People With Type 1 Diabetes

    • Completed
    • Age: 18 to 35 years
    • Results posted

    The aim of the study is to compare ESC recommendations on cardiovascular (CV) risk stratification with the achievement of a CAC (Coronary Artery Calcification).

    Trial name
    CACD1 (NCT05283538)
    Testing
    Coronary Artery Calcification Realization
    Where
    France
    Volunteers
    91 people
    Sponsor
    Poitiers University Hospital
    Can I take part? CACD1
  • Chronic Disease, Frail

    Functional Exercise and Nutrition Education Program for Older Adults

    • Completed
    • Age: 60 years and older
    • Results posted

    There is strong evidence that specific types of exercise can improve health and physical function in older adults. While community exercise classes exist, many older adults with chronic conditions may need guidance from…

    Conditions
    Chronic Disease, Frail, Diabetes Mellitus, Cancer
    Trial name
    MoveStrong (NCT04037436)
    Testing
    Strength and Balance Training & Nutrition Education, Usual Care
    Where
    5 sites in Canada
    Volunteers
    44 people
    Sponsor
    University of Waterloo
    Can I take part? MoveStrong
  • Isolated Aortic Stenosis, Mitral Regurgitation

    A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The purpose of this study is to determine whether recording heart sounds with an acoustic stethoscope, combined with artificial intelligence (computer information), will show similar abnormalities to an echocardiogram or cardiac…

    Trial name
    NCT04960280
    Testing
    ©VoqX stethoscope
    Where
    United States
    Volunteers
    400 people
    Sponsor
    Mayo Clinic
    Can I take part? NCT04960280
  • Chronic Heart Failure

    Acupuncture on Cardiac and Autonomic Function in Human Heart Failure

    • Completed
    • Age: 21 years and older
    • Surgery or procedure
    • Results posted

    Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function.

    Trial name
    NCT01804816
    Testing
    Acupuncture, No Intervention
    Where
    United States
    Volunteers
    14 people
    Sponsor
    The Cleveland Clinic
    Can I take part? NCT01804816

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in